NCT04152772

Brief Summary

The primary purpose of this study is to investigate the effects of tDCS timing on extinction memory in PTSD. A total of 90 participants will be randomized equally across one of three groups:

  1. 1.One group receiving active stimulation during extinction followed by sham stimulation during consolidation
  2. 2.One group receiving sham stimulation during extinction followed by active stimulation during consolidation
  3. 3.One group receiving sham stimulation both during extinction and consolidation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 5, 2019

Completed
17 days until next milestone

Study Start

First participant enrolled

November 22, 2019

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2024

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

October 21, 2025

Completed
Last Updated

October 21, 2025

Status Verified

October 1, 2025

Enrollment Period

4.2 years

First QC Date

October 31, 2019

Results QC Date

August 4, 2025

Last Update Submit

October 7, 2025

Conditions

Keywords

safety memoryPTSDtDCSventromedial prefrontal cortexfear conditioningcontext processing

Outcome Measures

Primary Outcomes (1)

  • Skin Conductance Responses

    Main protocol: Threat reactivity as quantified by skin conductance responses to a conditioned and subsequently extinguished stimulus versus a never conditioned stimulus.

    Study visit day 4: during administration of fear extinction memory.

Study Arms (3)

Active tDCS during extinction learning followed by sham tDCS during consolidation

ACTIVE COMPARATOR

Active tDCS will be applied during the extinction learning phase followed by sham tDCS during the consolidation phase.

Device: transcranial direct current stimulation

Sham tDCS during extinction learning followed by active tDCS during consolidation

ACTIVE COMPARATOR

Sham tDCS will be applied during the extinction learning phase followed by active tDCS during the consolidation phase.

Device: transcranial direct current stimulation

Sham tDCS during extinction learning followed by sham tDCS during consolidation

SHAM COMPARATOR

Sham tDCS will be applied during the extinction learning phase followed by sham tDCS during the consolidation phase.

Device: transcranial direct current stimulation

Interventions

Active tDCS will consist of 15 minutes of 2 mA intensity once, either applied during or after extinction learning.

Active tDCS during extinction learning followed by sham tDCS during consolidationSham tDCS during extinction learning followed by active tDCS during consolidationSham tDCS during extinction learning followed by sham tDCS during consolidation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary diagnosis of PTSD, assessed by the Structured Clinical Interview of DSM-5 (SCID);
  • aged 18-70;
  • ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent;
  • Stable psychiatric medication use or treatment for at least 6 weeks.

You may not qualify if:

  • Lifetime history of psychotic or bipolar disorder;
  • Current moderate or severe substance use disorder; if mild, not under the influence at time of study participation;
  • Acute suicidal or homicidal ideation as detected on screening instruments or in the investigator team's opinion, is likely to attempt suicide within 6 months;
  • current (or past) significant neurological disorder, injury, or other intracranial pathology including severe traumatic brain injury or lifetime history of a) seizure disorder b) primary or secondary CNS tumors c) stroke or d) cerebral aneurysm;
  • lifetime history of moderate or, current unstable medical conditions;
  • Any problems that would interfere with study participation, including MRI- or tDCS-related contraindications (e.g., implanted metallic devices/substances, metallic tattoos, pregnancy, claustrophobia, holes in the skull, skin abnormalities under stimulation sites), or indication of colorblindness, or presence of any other condition or circumstance that, in the opinion of the investigator team, has the potential to prevent study completion and/or inability to schedule visit days within the allotted time, and/or to have a confounding effect on outcome assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Butler Hospital

Providence, Rhode Island, 02906, United States

Location

Related Publications (1)

  • Faucher CR, Doherty RA, Philip NS, Harle ASM, Cole JJE, Van't Wout-Frank M. Is there a neuroscience-based, mechanistic rationale for transcranial direct current stimulation as an adjunct treatment for posttraumatic stress disorder? Behav Neurosci. 2021 Dec;135(6):702-713. doi: 10.1037/bne0000487. Epub 2021 Aug 2.

    PMID: 34338547BACKGROUND

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Limitations and Caveats

Enrollment disruptions due to COVID-19 pandemic resulted in a smaller size than planned (86%; n=62 across three groups out of n=72 planned) for primary outcome analysis and inadequate numbers (51%; n=37 across three groups out of n=72) for analyses of secondary MRI outcomes.

Results Point of Contact

Title
Mascha van 't Wout-Frank
Organization
Butler Hospital

Study Officials

  • Benjamin Greenberg, PhD, MD

    Butler Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Individuals deemed eligible for the study will be randomized to 1) receiving active tDCS during extinction learning; sham during extinction consolidation, 2) receiving sham during extinction learning; active tDCS during extinction consolidation, 3) receiving sham during extinction learning; sham during extinction consolidation. (Anticipated enrollment: 90 participants).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor (Research)

Study Record Dates

First Submitted

October 31, 2019

First Posted

November 5, 2019

Study Start

November 22, 2019

Primary Completion

January 31, 2024

Study Completion

January 31, 2024

Last Updated

October 21, 2025

Results First Posted

October 21, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations